SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Depotech(depo)
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
887 2 0 DEPO
Emcee:  trevor john wilkinson Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
62 John, I'm curious about the FDA review information, particularly the idea Czechsinthemail-8/8/1997
61 Mesotheliomas only rarely metastasize to other organs. They are very aggressiveSteven Brunnert-8/7/1997
60 Mesothelioma is a rare cancer of the chest or very rarely the abdomenal wall. Sleepman-8/7/1997
59 I wasn't familiar with malignant mesothelioma so I looked it up. "MesDr. John M. de Castro-8/6/1997
58 Do you know if they are looking into using depocyt or something like it for malSleepman-8/6/1997
57 It will be decided in December. The word I got from DEPO is that if the OncologDr. John M. de Castro-8/6/1997
56 Anybody know when the Onclolgic Advisory Committee is meeting on Depocyt? I Tom D-8/5/1997
55 Not necessarily. Certain therapeutic categories have gotten prioritized reviewsJames Silverman-7/15/1997
54 does the NDA review time correlate (strongly) with probability of approval e.g.Doug Baer-7/15/1997
53 There is an interview with DEPO's CEO available on the NASDAQ site nasdaq.Peter Silsbee-7/10/1997
52 I wouldnt go so far as to say there is no reason for DEPO's drop. The NDA James Silverman-7/9/1997
51 stock (and other bio-techs) is below IPO price for no fundamental reason (accorDoug Baer-7/9/1997
50 Depotech patent news: biz.yahoo.comCzechsinthemail-7/9/1997
49 Jim, Regarding the possible delays in DepoCyt, what is the likelihood of theirCzechsinthemail-7/8/1997
48 thanks for the information / morale booster, Jim.Doug Baer-7/8/1997
47 Doug, The drop appears to have little to do with the fundamentals and progressJames Silverman-7/8/1997
46 any hypotheses on the 1.25 point (9%) drop today? who among the SIers has lostDoug Baer-7/8/1997
45 John, Anything interesting from the conference call that wasn't covered inCzechsinthemail-7/7/1997
44 Some Depotech news today. Pharmacia & Upjohn to market DepoCyt outside U.SCzechsinthemail-7/7/1997
43 DEPO will hold a conference call to "provide a brief update on the CompanyDr. John M. de Castro-7/7/1997
42 I discovered a possible source of some of DEPO's recent price pullback. DECzechsinthemail-6/26/1997
41 Jim, Do you know what the milestone payments amount to and what the specific tCzechsinthemail-6/26/1997
40 Baird-I hadnt seen that the terms had been disclosed. $13M does not sound likeJames Silverman-6/26/1997
39 Jim, <i>Remember the terms of the buyback of Euro rights from CHIR have Czechsinthemail-6/25/1997
38 Baird, Remember the terms of the buyback of Euro rights from CHIR have not beeJames Silverman-6/25/1997
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News